Edwards Carladenise Armbrister bought CLOV
January 3, 2024 · Form 4 insider transaction
Edwards Carladenise Armbrister bought 206,185 shares of Clover Health Investments, Corp. at $0.97 per share, a transaction worth $200.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
206,185
Price
$0.97
Total value
$200.0K
Role—
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateJanuary 3, 2024
Filing dateJanuary 5, 2024
Shares owned after412,252
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 3, 2024, subject to the Reporting Person's continued service as a director through such vesting date.